pargyline has been researched along with Nerve Degeneration in 11 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In pargyline treated rats, 17 h after denervation, noradrenaline stores were 90% of control glands." | 5.26 | Electron microscopic evidence that bretylium and pargyline delay adrenergic nerve degeneration after sympathectomy of the pineal gland. ( Gomez-Dumm, GL; Perec, CJ; Sanz, NR; Stefano, FJ, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanz, NR | 1 |
| Gomez-Dumm, GL | 1 |
| Perec, CJ | 3 |
| Stefano, FJ | 3 |
| Arbilla, S | 2 |
| Lipska, BK | 1 |
| Chrapusta, SJ | 1 |
| Egan, MF | 1 |
| Weinberger, DR | 1 |
| Andringa, G | 1 |
| van Oosten, RV | 1 |
| Unger, W | 1 |
| Hafmans, TG | 1 |
| Veening, J | 1 |
| Stoof, JC | 1 |
| Cools, AR | 1 |
| Hedreen, J | 1 |
| Holzwarth-McBride, MA | 1 |
| Sladek, JR | 1 |
| Knigge, KM | 1 |
| Butcher, LL | 1 |
| Luthman, J | 1 |
| Jonsson, G | 1 |
| Clineschmidt, BV | 1 |
| Sims, KL | 1 |
| Bloom, FE | 1 |
11 other studies available for pargyline and Nerve Degeneration
| Article | Year |
|---|---|
Electron microscopic evidence that bretylium and pargyline delay adrenergic nerve degeneration after sympathectomy of the pineal gland.
Topics: Adrenergic Fibers; Animals; Bretylium Compounds; Female; Microscopy, Electron; Nerve Degeneration; N | 1982 |
Delay by bretylium of adrenergic nerve degeneration after sympathectomy of the submaxillary gland.
Topics: Animals; Bretylium Compounds; Dose-Response Relationship, Drug; Drug Interactions; Female; Metaramin | 1980 |
Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol.
Topics: Animals; Corpus Striatum; Dopamine; Female; Frontal Lobe; Haloperidol; Handling, Psychological; Hipp | 1995 |
Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
Topics: Animals; Antibodies; Apoptosis; Behavior, Animal; Body Weight; Denervation; Dopamine; Exploratory Be | 2000 |
Neuronal degeneration caused by lateral ventricular injection of 6-hydroxy-dopamine. I. The ventral premammillary nucleus and other cell groups.
Topics: Animals; Axonal Transport; Cerebral Aqueduct; Hydroxydopamines; Hypothalamus, Middle; Injections, In | 1978 |
Delay in nerve degeneration after sympathectomy of the submaxillary gland of the rat by treatment with pargyline, nialamide or beta-TM-10.
Topics: Animals; Choline; Female; In Vitro Techniques; Metaraminol; Monoamine Oxidase; Nerve Degeneration; N | 1977 |
Monosodium glutamate induced lesions of the arcurate nucleus. II. Fluorescence histochemistry of catecholamines.
Topics: Animals; Catecholamines; Female; Fluorescence; Histocytochemistry; Hypothalamus; Hypothalamus, Anter | 1976 |
Degenerative processes after punctate intracerebral administration of 6-hydroxydopamine.
Topics: Acetylcholinesterase; Animals; Brain; Dihydrolipoamide Dehydrogenase; Drug Synergism; Female; Hydrox | 1975 |
Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adrenergic Fibers; Animal | 1986 |
Spinal monoamines and the toxic interaction between monoamine oxidase inhibitors and tricyclic antidepressants.
Topics: Animals; Antidepressive Agents; Cats; Drug Interactions; Female; Hydrazines; Imipramine; Male; Monoa | 1972 |
Rat brain L-3,4-dihydroxyphenylalanine and L-5-hydroxytryptophan decarboxylase activities: differential effect of 6-hydroxydopamine.
Topics: 5-Hydroxytryptophan; Animals; Brain Stem; Carboxy-Lyases; Catecholamines; Cerebellum; Cerebral Corte | 1973 |